INS and type 2 diabetes mellitus: However, other CVD outcome trials failed to show any effect (beneficial or detrimental) of insulin therapy on CVD morbidity or mortality (Gerstein et al., 2012), confirming the cardiovascular safety of insulin treatment in T2D patients.